More on JNJ

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+1.8% Growth)
- Ratings (3.8 Score)
- Holders
- Dividends (2.7% Yield)
- Event Driven Deals
- FDA Archive

Financials

Income Statement
Balance Sheet
Cash Flow Statement

Upcoming Events

- Earnings (10/13/16 *Est.)
- Spin-Off (12/31/15 *Est)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

JNJ Cash Flow Statement

Click line-items for a historical chart and %
CASH FLOW FROM OPERATING ACTIVITIES
Net earnings
Adjustments to reconcile net earnings to cash flows from operating activities:
Depreciation and amortization of property and intangibles 1.79B
Stock based compensation 479M
Deferred tax provision 115M
Accounts receivable allowances -4M
Changes in assets and liabilities, net of effects from acquisitions:
Increase in accounts receivable -1.1B
Increase in inventories -443M
Decrease in accounts payable and accrued liabilities -1.05B
Increase in other current and non-current assets -630M
Increase in other current and non-current liabilities -866M
NET CASH FLOWS FROM OPERATING ACTIVITIES 6.75B
CASH FLOWS FROM INVESTING ACTIVITIES
Additions to property, plant and equipment -1.4B
Proceeds from the disposal of assets 685M
Acquisitions, net of cash acquired -730M
Purchases of investments -17.51B
Sales of investments 18.78B
Other -38M
NET CASH USED BY INVESTING ACTIVITIES -215M
CASH FLOWS FROM FINANCING ACTIVITIES
Dividends to shareholders -4.27B
Repurchase of common stock -4.75B
Proceeds from short-term debt 118M
Retirement of short-term debt -4.69B
Proceeds from long-term debt 11.95B
Retirement of long-term debt -936M
Proceeds from the exercise of stock options/ excess tax benefits
NET CASH USED BY FINANCING ACTIVITIES -1.64B
Effect of exchange rate changes on cash and cash equivalents 12M
Decrease in cash and cash equivalents 4.91B
Cash and Cash equivalents, beginning of period 13.73B
CASH AND CASH EQUIVALENTS, END OF PERIOD 18.64B
Acquisitions
Fair value of assets acquired 744M
Fair value of liabilities assumed and non-controlling interests -14M
Net cash paid for acquisitions 730M